GeoPark (NYSE:GPRK – Get Rating) and Portage Biotech (NASDAQ:PRTG – Get Rating) are both small-cap oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings and profitability.
This table compares GeoPark and Portage Biotech’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
GeoPark has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Comparatively, Portage Biotech has a beta of 0.27, suggesting that its stock price is 73% less volatile than the S&P 500.
Insider and Institutional Ownership
37.5% of GeoPark shares are owned by institutional investors. Comparatively, 4.6% of Portage Biotech shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares GeoPark and Portage Biotech’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|GeoPark||$688.54 million||1.20||$61.13 million||$1.67||8.20|
|Portage Biotech||N/A||N/A||-$15.83 million||N/A||N/A|
GeoPark has higher revenue and earnings than Portage Biotech.
This is a summary of recent ratings and target prices for GeoPark and Portage Biotech, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Portage Biotech has a consensus target price of $34.25, suggesting a potential upside of 359.12%. Given Portage Biotech’s higher possible upside, analysts clearly believe Portage Biotech is more favorable than GeoPark.
GeoPark beats Portage Biotech on 6 of the 9 factors compared between the two stocks.
About GeoPark (Get Rating)
GeoPark Limited engages in the exploration, development, and production of oil and gas reserves in Chile, Colombia, Brazil, Argentina, and Ecuador. As of December 31, 2021, the company had working and/or economic interests in 42 hydrocarbons blocks. It had net proved reserves of 87.8 million barrels of oil equivalent. GeoPark Limited has a strategic partnership with ONGC Videsh to jointly acquire, invest in, and create value from upstream oil and gas projects across Latin America. The company was formerly known as GeoPark Holdings Limited and changed its name to GeoPark Limited in July 2013. GeoPark Limited was founded in 2002 and is based in Bogotá, Colombia.
About Portage Biotech (Get Rating)
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for GeoPark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoPark and related companies with MarketBeat.com's FREE daily email newsletter.